Diabetes Drug Prior Authorization — AI-Assisted Approval

Prior authorization is the paperwork hurdle that stands between you and a medicine your clinician has already prescribed — and it is one of the most common reasons GLP-1 drugs and CGMs get delayed or denied. This page explains what prior authorization is, why these items get denied, how to appeal, and what documentation strengthens your case. It also introduces an AI tool that drafts the request so you and your clinician can move faster.

What prior authorization is

Prior authorization is a requirement by many insurers that your clinician get approval before the plan will pay for certain medicines or devices. Insurers use it to control cost and confirm the item meets their coverage criteria. It applies most often to newer, higher-cost therapies — which is exactly where diabetes care has been moving.

Why GLP-1 drugs and CGMs get denied

Denials usually come down to the insurer's specific criteria not being clearly met in the paperwork, not the treatment being wrong for you.

• The plan requires you to try a cheaper medicine first (step therapy) and that history was not documented.
• The stated diagnosis or A1c does not match the plan's coverage rule for that drug.
• The medicine was prescribed for weight management under a plan that only covers it for diabetes, or vice versa.
• A continuous glucose monitor was requested without documenting insulin use or the monitoring need the plan requires.
• Simple administrative gaps — missing codes, dates, or clinician signatures.

How to appeal a denial

A denial is not the end. Most plans have a formal appeal process, and many denials are overturned when the documentation is completed properly.

1. Read the denial letter carefully to find the exact reason given.
2. Ask your clinic for the records that address that reason — prior medicines tried, A1c values, diagnosis codes.
3. Have your clinician submit an appeal or a letter of medical necessity referencing the plan's own criteria.
4. If the first appeal fails, ask about a peer-to-peer review or an external independent review.
5. Keep copies and note every date and reference number.

Documentation that strengthens your case

• Your diagnosis with the correct code and date.
• Recent A1c and glucose data showing the clinical need.
• A record of prior medicines tried and why they were insufficient or not tolerated.
• Relevant comorbidities such as heart or kidney disease that guidelines link to the therapy.
• A clear statement of medical necessity from your clinician.

The AI-assisted drafting tool

The AI tool drafts the prior-authorization request or appeal letter using the details you and your clinician provide, structuring it around the plan's stated criteria so nothing obvious is missing. It speeds up a tedious task, but a clinician must review, complete, and submit it — the tool assists, it does not replace professional judgement, and it cannot guarantee approval.

Frequently Asked Questions

Why was my GLP-1 prescription denied?

Most often because the plan's criteria were not fully documented — for example a required first-line medicine, the covered diagnosis, or A1c evidence. These gaps are usually fixable on appeal.

How long does prior authorization take?

It varies by insurer, from a few days to a couple of weeks. Expedited reviews exist for urgent cases; ask your clinic to request one if appropriate.

Can I appeal more than once?

Yes. If the first appeal is denied, you can often request a peer-to-peer review between your clinician and the plan, and then an external independent review.

Does the AI tool submit the request for me?

No. It drafts the paperwork to save time, but your clinician must review and submit it, since only they can attest to medical necessity.